Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement.

[1]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[2]  J. Amsterdam,et al.  Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. , 1998, The American journal of psychiatry.

[3]  S. Leatherman,et al.  Using Claims Data for Epidemiologic Research: The Concordance of Claims-Based Criteria With the Medical Record and Patient Survey for Identifying a Hypertensive Population , 1993, Medical care.

[4]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[5]  K. Wells,et al.  How can care for depression become more cost-effective? , 1995, JAMA.

[6]  Wayne Katon,et al.  Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.

[7]  E H Wagner,et al.  Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.

[8]  C. Sennett.  Perspective: Moving Ahead, Measure By Measure , 1998 .

[9]  A. Rush,et al.  Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. , 1998, Archives of general psychiatry.

[10]  Compliance and quality of response are major contributors to cost‐effective antidepressant therapy , 1994 .

[11]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[12]  W. Katon,et al.  Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. , 1996, JAMA.

[13]  T. Croghan,et al.  The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. , 1998, Archives of general psychiatry.

[14]  L. George,et al.  Depression, disability days, and days lost from work in a prospective epidemiologic survey. , 1990, JAMA.

[15]  D M Eddy,et al.  Performance measurement: problems and solutions. , 1998, Health affairs.

[16]  E. Berndt,et al.  The economic burden of depression in 1990. , 1993, The Journal of clinical psychiatry.

[17]  I. Anderson,et al.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis , 1995, BMJ.

[18]  M. Thase,et al.  Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. , 1998, JAMA.

[19]  G. Engquist,et al.  Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. , 1997, The American journal of managed care.

[20]  K. Wells,et al.  Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. , 1994, The American journal of psychiatry.